Table III.
Ezrin | E-cadherin | ||||||
---|---|---|---|---|---|---|---|
|
|
||||||
Sample | n | (+) | (−) | P-value | (+) | (−) | P-value |
DRP-1-positive | 27 | 22 | 5 | 15 | 12 | ||
DRP-1-negative | 49 | 47 | 2 | <0.05 | 6 | 43 | <0.01 |
χ2 value | 4.338 | 16.330 |
ESCC, esophageal squamous cell carcinoma.
Ezrin | E-cadherin | ||||||
---|---|---|---|---|---|---|---|
|
|
||||||
Sample | n | (+) | (−) | P-value | (+) | (−) | P-value |
DRP-1-positive | 27 | 22 | 5 | 15 | 12 | ||
DRP-1-negative | 49 | 47 | 2 | <0.05 | 6 | 43 | <0.01 |
χ2 value | 4.338 | 16.330 |
ESCC, esophageal squamous cell carcinoma.